Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 77679-27-7
- Molecular formula
- C8H10IN3
- Molecular weight
- 275.09 g/mol
- Drug class
- Norepinephrine analogueadrenergic-neuron blocking agent and radiopharmaceutical imaging precursor
- Mechanism of action
- Taken up by the norepinephrine transporter in adrenergic nerve terminals and stored in presynaptic vesicles, with accumulation in adrenergically innervated tissues and neural-crest-derived tumours. When radiolabelled with iodine-123 or iodine-131, it enables diagnostic imaging or targeted radiotherapy.
- Indications / reported uses
- Diagnostic imaging of pheochromocytoma, neuroblastoma and selected other adrenergic tumours with iodine-123-labelled iobenguane.
- Targeted radiotherapy of selected unresectable or metastatic pheochromocytoma/paraganglioma with iodine-131-labelled iobenguane, where authorised.
Sources: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane · https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c89d3ecc-4f4c-4566-8808-79152344194d · https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131